Literature DB >> 1517384

Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy.

J Itskovitz1, S Rubattu, J Levron, J E Sealey.   

Abstract

Prorenin is not only the biosynthetic precursor of renin; under certain circumstances in vitro prorenin exhibits reversible intrinsic renin activity and can form angiotensin from renin substrate with or without cleavage of the prosequence. Prorenin is the predominant form of renin synthesized by reproductive organs (ovary, chorion laeve of the placenta, uterine decidua). Its plasma concentrations increases 10-fold throughout pregnancy to 10-100 times that of renin; amniotic fluid prorenin concentration is even higher. No data are available of gestational fluid prorenin concentrations during early pregnancy. For the first 10 weeks there are two gestational cavities; the chorionic cavity then disappears and the smaller amniotic cavity becomes predominant. In this study we measured prorenin, renin, renin substrate and hCG in fluid aspirated from gestational sacs during the first trimester of gestation (predominantly chorionic) and during the second and third trimesters (amniotic). Seventeen patients had amniocentesis during the second or third trimester. Nine patients underwent selective abortion of multiple pregnancy at 7-12 weeks gestation. One patient underwent surgery at 5 5/7 weeks (26 days after conception) for a tubal pregnancy. Second and third trimester amniotic fluid prorenin maximum velocity (Vmax) (16 and 3 sacs, respectively) averaged 6,100 +/- 1,700 (SD) and 1,930 +/- 760 ng/mL.h, respectively (i.e. 1,700 and 540 ng/L.s). In gestational fluid collected before 8 weeks, prorenin Vmax was 10-fold higher, averaging 62,500 +/- 40,000 ng/mL.h (17,000 ng/L.s). The concentration was 140,000 ng/mL.h (39,000 ng/L.s) in the 5 5/7 week tubal pregnancy. In sharp contrast, at 10-12 weeks gestation (n = 3) prorenin Vmax was only 260 +/- 114 ng/mL.h (72 ng/L.s); human CG was also highest before 8 weeks (276,500 +/- 110,900 IU/L) and lowest at 10-12 weeks (1210 +/- 540 IU/L) with intermediate levels occurring later in pregnancy. This study shows that the highest biological levels of prorenin yet detected (close to 1 micrograms protein/mL) occur in gestational sacs in early pregnancy, consistent with a role for the renin-angiotensin system in embryonic development or placentation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517384     DOI: 10.1210/jcem.75.3.1517384

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin.

Authors:  Manne Krop; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

2.  A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes.

Authors:  L Ringholm; U Pedersen-Bjergaard; B Thorsteinsson; F Boomsma; P Damm; E R Mathiesen
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

Review 3.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 4.  The (pro)renin receptor. A decade of research: what have we learned?

Authors:  Manne Krop; Xifeng Lu; A H Jan Danser; Marcel E Meima
Journal:  Pflugers Arch       Date:  2012-04-28       Impact factor: 3.657

5.  The synthesis, secretion and uptake of prorenin in human amnion.

Authors:  Kirsty G Pringle; Yu Wang; Eugenie R Lumbers
Journal:  Physiol Rep       Date:  2015-04

Review 6.  Direct renin inhibition--a promising strategy for renal protection?

Authors:  Sławomir Lizakowski; Leszek Tylicki; Bolesław Rutkowski
Journal:  Med Sci Monit       Date:  2013-06-12

Review 7.  The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Giorgio Gentile; Gianpaolo Reboldi
Journal:  Vasc Health Risk Manag       Date:  2008

8.  The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS.

Authors:  Daniel Griffin; Claudio Benadiva; Tara Budinetz; Carolina Sueldo; Andrea DiLuigi; John Nulsen; Lawrence Engmann
Journal:  Contemp Clin Trials Commun       Date:  2017-08-17

9.  Human kidney pericytes produce renin.

Authors:  Ania Stefanska; Christopher Kenyon; Helen C Christian; Charlotte Buckley; Isaac Shaw; John J Mullins; Bruno Péault
Journal:  Kidney Int       Date:  2016-09-24       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.